Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-171

Knowing that makes this upcoming trial even more likely to succeed, because they simply won't enroll anyone who's had CLBP for more than 5-6 years.


That's right @stockrock .... they will do exactly the same thing with the "Eligibility Criteria" for the additional COVID-19 ARDS trial for under 65's as well now that they have so much data, biomarkers etc etc

..... and sadly I continue to see why SI is pushing forward with the COVID-19 ARDS trial - you don't have to look far to see why more treatments are needed (last 2 days in the USA) .... I just hope the NIH are wanting to pay for it again this time around ?


https://www.worldometers.info/coronavirus/